Alnylam Pharmaceuticals, Inc. (ALNY) Reports Q3 Loss of 31c/Share
Go back to Alnylam Pharmaceuticals, Inc. (ALNY) Reports Q3 Loss of 31c/Share| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 282.59 +4.50 (1.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $278.09 | 52 Week High | $109.10 | |||
| Open | $278.42 | 52 Week Low | $31.38 | |||
| Day High | $285.19 | P/E | N/A | |||
| Day Low | $278.17 | EPS | $-1.45 | |||
| Volume | 471,150 | |||||
